Outcome of Allogeneic and Autologous Hematopoietic Cell Transplant for High-Risk Peripheral T-Cell Lymphomas (PTCLs): a Retrospective Analysis From a Chinese Center

Highlights • This analysis showed that HCT can benefit patients with high-risk PTCL in both remission and primary refractory setting. • This analysis found that alloHCT recipients in primary refractory setting had superior OS compared with corresponding patients who received autoHCT.

Saved in:
Bibliographic Details
Published inBiology of blood and marrow transplantation
Main Authors Huang, Haiwen, Jiang, Yibin, Wang, Qiangli, Guo, Lingchuan, Jin, Zhengming, Fu, Zhengzheng, Han, Yue, Sun, Aining, Liu, Wei, Ruan, Jia, Wu, Depei
Format Journal Article
LanguageEnglish
Published 2017
Subjects
Hematology, Oncology and Palliative Medicine
autologous transplantation
peripheral T-cell lymphomas
allogeneic transplantation
Online AccessGet full text

Cover

More Information
Summary:Highlights • This analysis showed that HCT can benefit patients with high-risk PTCL in both remission and primary refractory setting. • This analysis found that alloHCT recipients in primary refractory setting had superior OS compared with corresponding patients who received autoHCT.
ISSN:1083-8791
1523-6536
DOI:10.1016/j.bbmt.2017.04.021